Published Date：Mar.2021
Industry：Pharma & Healthcare
Pages：107 Table Number：127
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Compounding Pharmacies market in this environment. In terms of revenue, this research report indicated that the global Compounding Pharmacies market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Compounding Pharmacies industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The Fagron aims at producing XX K Units Compounding Pharmacies in 2020, with XX % production to take place in global market, PharMEDium accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Compounding Pharmacies Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Compounding Pharmacies Market? Fagron PharMEDium Dougherty’s Pharmacy ITC Compounding Pharmacy Fresenius Kabi Clinigen Group Absolute Pharmacy McGuff Compounding Pharmacy Services Harrow Health ... Major Type of Compounding Pharmacies Covered in XYZResearch report: Oral Topical Ophthalmic Injectables Others Application Segments Covered in XYZResearch Market Adult Pediatric Geriatric Veterinary For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Compounding Pharmacies Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Oral -Product Introduction and Major Manufacturers 1.1.2 Topical -Product Introduction and Major Manufacturers 1.1.3 Ophthalmic -Product Introduction and Major Manufacturers 1.1.4 Injectables -Product Introduction and Major Manufacturers 1.1.5 Others -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Compounding Pharmacies Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027) 2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027) 3 Regional Market Analysis 3.1 China Compounding Pharmacies Market 3.1.1 Top Companies leading Compounding Pharmacies Development in China (2016-2021) 3.1.2 Sales Value of Major Company in China Market (2016-2021) 3.1.3 China Compounding Pharmacies Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2026-2027) 3.2 EU Compounding Pharmacies Market 3.2.1 Top Companies leading Compounding Pharmacies Development in EU (2016-2021) 3.2.2 Sales Value of Major Company in EU Market (2016-2021) 3.2.3 EU Compounding Pharmacies Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2026-2027) 3.3 USA Compounding Pharmacies Market 3.3.1 Top Companies leading Compounding Pharmacies Development in USA (2016-2021) 3.3.2 Sales Value of Major Company in USA Market (2016-2021) 3.3.3 USA Compounding Pharmacies Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2026-2027) 3.4 Japan Compounding Pharmacies Market 3.4.1 Top Companies leading Compounding Pharmacies Development in Japan (2016-2021) 3.4.2 Sales Value of Major Company in Japan Market (2016-2021) 3.4.3 Japan Compounding Pharmacies Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2026-2027) 3.5 India Compounding Pharmacies Market 3.5.1 Top Companies leading Compounding Pharmacies Development in India (2016-2021) 3.5.2 Sales Value of Major Company in India Market (2016-2021) 3.5.3 India Compounding Pharmacies Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2026-2027) 3.6 Southeast Asia Compounding Pharmacies Market 3.6.1 Top Companies leading Compounding Pharmacies Development in Southeast Asia (2016-2021) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021) 3.6.3 Southeast Asia Compounding Pharmacies Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2026-2027) 3.7 South America Compounding Pharmacies Market 3.7.1 Top Companies leading Compounding Pharmacies Development in South America (2016-2021) 3.7.2 Sales Value of Major Company in South America Market (2016-2021) 3.7.3 South America Compounding Pharmacies Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2026-2027) 4 Value Chain (Impact of COVID-19) 4.1 Compounding Pharmacies Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Compounding Pharmacies Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2027) 5.1 Global Compounding Pharmacies Sales and Growth Rate (2021-2027) 5.2 Global Compounding Pharmacies Sales Value and Growth Rate (2021-2027) 6 Compounding Pharmacies Competitive Analysis 6.1 Fagron 6.1.1 Fagron Company Profiles 6.1.2 Fagron Product Introduction 6.1.3 Fagron Compounding Pharmacies Production, Revenue (2016-2021) 6.1.4 SWOT Analysis 6.2 PharMEDium 6.2.1 PharMEDium Company Profiles 6.2.2 PharMEDium Product Introduction 6.2.3 PharMEDium Compounding Pharmacies Production, Revenue (2016-2021) 6.2.4 SWOT Analysis 6.3 Dougherty’s Pharmacy 6.3.1 Dougherty’s Pharmacy Company Profiles 6.3.2 Dougherty’s Pharmacy Product Introduction 6.3.3 Dougherty’s Pharmacy Compounding Pharmacies Production, Revenue (2016-2021) 6.3.4 SWOT Analysis 6.4 ITC Compounding Pharmacy 6.4.1 ITC Compounding Pharmacy Company Profiles 6.4.2 ITC Compounding Pharmacy Product Introduction 6.4.3 ITC Compounding Pharmacy Compounding Pharmacies Production, Revenue (2016-2021) 6.4.4 SWOT Analysis 6.5 Fresenius Kabi 6.5.1 Fresenius Kabi Company Profiles 6.5.2 Fresenius Kabi Product Introduction 6.5.3 Fresenius Kabi Compounding Pharmacies Production, Revenue (2016-2021) 6.5.4 SWOT Analysis 6.6 Clinigen Group 6.6.1 Clinigen Group Company Profiles 6.6.2 Clinigen Group Product Introduction 6.6.3 Clinigen Group Compounding Pharmacies Production, Revenue (2016-2021) 6.6.4 SWOT Analysis 6.7 Absolute Pharmacy 6.7.1 Absolute Pharmacy Company Profiles 6.7.2 Absolute Pharmacy Product Introduction 6.7.3 Absolute Pharmacy Compounding Pharmacies Production, Revenue (2016-2021) 6.7.4 SWOT Analysis 6.8 McGuff Compounding Pharmacy Services 6.8.1 McGuff Compounding Pharmacy Services Company Profiles 6.8.2 McGuff Compounding Pharmacy Services Product Introduction 6.8.3 McGuff Compounding Pharmacy Services Compounding Pharmacies Production, Revenue (2016-2021) 6.8.4 SWOT Analysis 6.9 Harrow Health 6.9.1 Harrow Health Company Profiles 6.9.2 Harrow Health Product Introduction 6.9.3 Harrow Health Compounding Pharmacies Production, Revenue (2016-2021) 6.9.4 SWOT Analysis 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2016-2021) Figure Global Compounding Pharmacies Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2027) Table CAGR in Terms of Production of Each Type (2026-2027) Table CAGR in Terms of Production of Each Application (2026-2027) Table Global Compounding Pharmacies Sales (K Unit) by Type (2026-2027) Figure Global Compounding Pharmacies Sales (K Unit) and Growth Rate (2026-2027) Figure Global Compounding Pharmacies Sales Market Share (%) by Type (2019 -2020) Table Global Compounding Pharmacies Sales Value (Million USD) by Type (2026-2027) Figure Global Compounding Pharmacies Sales Value (Million USD) and Growth Rate (2026-2027) Figure Global Compounding Pharmacies Sales Value Market Share (%) by Type (2019-2020) Table Global Compounding Pharmacies Sales (K Unit) by Application (2026-2027) Table China Compounding Pharmacies Sales (K Unit) of Major Company (2016-2021) Table China Compounding Pharmacies Sales Market Share of Major Company (2016-2021) Table China Compounding Pharmacies Sales Value (Million USD) of Major Company (2016-2021) Figure China Compounding Pharmacies Sales Value (Million USD) and Growth Rate (2016-2021) Table China Compounding Pharmacies Sales Value Share of Major Company (2016-2021) Table China Compounding Pharmacies Price (USD/Unit), by Type (2019-2020) Table China Compounding Pharmacies Sales (Unit) by Type (2026-2027) Figure China Compounding Pharmacies Sales (Unit) by Type (2026-2027) Table EU Compounding Pharmacies Sales (K Unit) of Major Company (2016-2021) Table EU Compounding Pharmacies Sales Market Share of Major Company (2016-2021) Table EU Compounding Pharmacies Sales Value (Million USD) of Major Company (2016-2021) Figure EU Compounding Pharmacies Sales Value (Million USD) and Growth Rate (2016-2021) Table EU Compounding Pharmacies Sales Value Share of Major Company (2016-2021) Table EU Compounding Pharmacies Price (USD/Unit), by Type (2019-2020) Table EU Compounding Pharmacies Sales (Unit) by Type (2026-2027) Figure EU Compounding Pharmacies Sales (Unit) by Type (2026-2027) Table USA Compounding Pharmacies Sales (K Unit) of Major Company (2016-2021) Table USA Compounding Pharmacies Sales Market Share of Major Company (2016-2021) Table USA Compounding Pharmacies Sales Value (Million USD) of Major Company (2016-2021) Figure USA Compounding Pharmacies Sales Value (Million USD) and Growth Rate (2016-2021) Table USA Compounding Pharmacies Sales Value Share of Major Company (2016-2021) Table USA Compounding Pharmacies Price (USD/Unit), by Type (2019-2020) Table USA Compounding Pharmacies Sales (Unit) by Type (2026-2027) Figure USA Compounding Pharmacies Sales (Unit) by Type (2026-2027) Table Japan Compounding Pharmacies Sales (K Unit) of Major Company (2016-2021) Table Japan Compounding Pharmacies Sales Market Share of Major Company (2016-2021) Table Japan Compounding Pharmacies Sales Value (Million USD) of Major Company (2016-2021) Figure Japan Compounding Pharmacies Sales Value (Million USD) and Growth Rate (2016-2021) Table Japan Compounding Pharmacies Sales Value Share of Major Company (2016-2021) Table Japan Compounding Pharmacies Price (USD/Unit), by Type (2019-2020) Table Japan Compounding Pharmacies Sales (Unit) by Type (2026-2027) Figure Japan Compounding Pharmacies Sales (Unit) by Type (2026-2027) Table India Compounding Pharmacies Sales (K Unit) of Major Company (2016-2021) Table India Compounding Pharmacies Sales Market Share of Major Company (2016-2021) Table India Compounding Pharmacies Sales Value (Million USD) of Major Company (2016-2021) Figure India Compounding Pharmacies Sales Value (Million USD) and Growth Rate (2016-2021) Table India Compounding Pharmacies Sales Value Share of Major Company (2016-2021) Table India Compounding Pharmacies Price (USD/Unit), by Type (2019-2020) Table India Compounding Pharmacies Sales (Unit) by Type (2026-2027) Figure India Compounding Pharmacies Sales (Unit) by Type (2026-2027) Table Southeast Asia Compounding Pharmacies Sales (K Unit) of Major Company (2016-2021) Table Southeast Asia Compounding Pharmacies Sales Market Share of Major Company (2016-2021) Table Southeast Asia Compounding Pharmacies Sales Value (Million USD) of Major Company (2016-2021) Figure Southeast Asia Compounding Pharmacies Sales Value (Million USD) and Growth Rate (2016-2021) Table Southeast Asia Compounding Pharmacies Sales Value Share of Major Company (2016-2021) Table Southeast Asia Compounding Pharmacies Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Compounding Pharmacies Sales (Unit) by Type (2026-2027) Figure Southeast Asia Compounding Pharmacies Sales (Unit) by Type (2026-2027) Table South America Compounding Pharmacies Sales (K Unit) of Major Company (2016-2021) Table South America Compounding Pharmacies Sales Market Share of Major Company (2016-2021) Table South America Compounding Pharmacies Sales Value (Million USD) of Major Company (2016-2021) Figure South America Compounding Pharmacies Sales Value (Million USD) and Growth Rate (2016-2021) Table South America Compounding Pharmacies Sales Value Share of Major Company (2016-2021) Table South America Compounding Pharmacies Price (USD/Unit), by Type (2019-2020) Table South America Compounding Pharmacies Sales (Unit) by Type (2026-2027) Figure South America Compounding Pharmacies Sales (Unit) by Type (2026-2027) Figure Value Chain Structure of Compounding Pharmacies Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Compounding Pharmacies Figure Cost Structure of Compounding Pharmacies in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2027) Table Regional Market Sales Share (2021-2027) Figure Global Compounding Pharmacies Sales (Unit), Growth Rate & Market Share (2021-2027) Table Regional Market Sales Value (Million USD) (2021-2027) Table Regional Market Sales Value Share (2021-2027) Figure Global Compounding Pharmacies Sales Value (Million USD), Growth Rate & Market Share (2021-2027) Table Fagron Profiles Table Fagron Compounding Pharmacies Product Introduction Table Fagron Compounding Pharmacies Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Fagron SWOT Analysis Table PharMEDium Profiles Table PharMEDium Compounding Pharmacies Product Introduction Table PharMEDium Compounding Pharmacies Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure PharMEDium SWOT Analysis Table Dougherty’s Pharmacy Profiles Table Dougherty’s Pharmacy Compounding Pharmacies Product Introduction Table Dougherty’s Pharmacy Compounding Pharmacies Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Dougherty’s Pharmacy SWOT Analysis Table ITC Compounding Pharmacy Profiles Table ITC Compounding Pharmacy Compounding Pharmacies Product Introduction Table ITC Compounding Pharmacy Compounding Pharmacies Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure ITC Compounding Pharmacy SWOT Analysis Table Fresenius Kabi Profiles Table Fresenius Kabi Compounding Pharmacies Product Introduction Table Fresenius Kabi Compounding Pharmacies Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Fresenius Kabi SWOT Analysis Table Clinigen Group Profiles Table Clinigen Group Compounding Pharmacies Product Introduction Table Clinigen Group Compounding Pharmacies Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Clinigen Group SWOT Analysis Table Absolute Pharmacy Profiles Table Absolute Pharmacy Compounding Pharmacies Product Introduction Table Absolute Pharmacy Compounding Pharmacies Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Absolute Pharmacy SWOT Analysis Table McGuff Compounding Pharmacy Services Profiles Table McGuff Compounding Pharmacy Services Compounding Pharmacies Product Introduction Table McGuff Compounding Pharmacy Services Compounding Pharmacies Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure McGuff Compounding Pharmacy Services SWOT Analysis Table Harrow Health Profiles Table Harrow Health Compounding Pharmacies Product Introduction Table Harrow Health Compounding Pharmacies Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021)
